Literature DB >> 26604272

Systemic Biomarkers in 2-Phase Antibiotic Periodontal Treatment: A Randomized Clinical Trial.

C Giannopoulou1, N Cionca2, A Almaghlouth3, J Cancela2, D S Courvoisier4, A Mombelli2.   

Abstract

Accumulating evidence suggests that periodontal infections may have an impact on systemic health. In patients with untreated periodontitis, very high values for several inflammatory markers in serum are expressed simultaneously. We investigated to what extent these peak values change after nonsurgical and surgical periodontal treatment, with adjunctive antibiotics administered during the first or the second treatment phase. In a single-center, randomized, placebo-controlled, and double-masked clinical trial, 80 patients with chronic or aggressive periodontitis were randomized into 2 treatment groups: group A, receiving systemic amoxicillin and metronidazole during the first, nonsurgical phase of periodontal therapy (phase 1), and group B, receiving the antibiotics during the second, surgical phase (phase 2). Serum samples were obtained at baseline (BL), 3 mo after phase 1 (M3), and 6 and 12 mo after phase 2 (M6, M12). Samples were evaluated for 15 cytokines and 9 acute-phase proteins using the Bio-Plex bead array multianalyte detection system. For each analyte, peak values were defined as greater than mean +2 SD of measurements found in 40 periodontally healthy persons. Sixty-six patients showed a peak value of at least 1 analyte at BL. At M12, the number of these patients was only 36 (P = 0.0002). This decrease was stronger in group A (BL: 35, M12: 19, P = 0.0009) than in group B (BL: 31, M12: 17, P = 0.14). Twenty patients displayed peak values of at least 4 biomarkers at BL. The nonsurgical therapy delivered in the first phase reduced most of these peaks (group A, BL: 9, M3: 4, P = 0.17; group B, BL: 11, M3: 2, P = 0.01), irrespective of adjunctive antibiotics. The reductions obtained at M3 were maintained until M12 in both groups. Initial, nonsurgical periodontal therapy reduced the incidence of peak levels of inflammatory markers. Antibiotics and further surgical therapy did not enhance the effect (Clinicaltrials.gov NCT02197260). © International & American Associations for Dental Research 2015.

Entities:  

Keywords:  acute phase proteins; antimicrobials; clinical research; cytokines; periodontal therapy; serum

Mesh:

Substances:

Year:  2015        PMID: 26604272     DOI: 10.1177/0022034515618949

Source DB:  PubMed          Journal:  J Dent Res        ISSN: 0022-0345            Impact factor:   6.116


  3 in total

1.  Systemic inflammatory burden and local inflammation in periodontitis: What is the link between inflammatory biomarkers in serum and gingival crevicular fluid?

Authors:  Alkisti Zekeridou; Andrea Mombelli; Jose Cancela; Delphine Courvoisier; Catherine Giannopoulou
Journal:  Clin Exp Dent Res       Date:  2019-01-24

Review 2.  Effects of timing of adjunctive systemic antibiotics on the clinical outcome of periodontal therapy: A systematic review.

Authors:  Lamiaa Abdallaoui-Maan; Amal Bouziane
Journal:  J Clin Exp Dent       Date:  2020-03-01

3.  Antibiotic effects against periodontal bacteria in organ cultured tissue.

Authors:  Masaaki Takeshita; Akira Haraguchi; Mayumi Miura; Takafumi Hamachi; Takao Fukuda; Terukazu Sanui; Aiko Takano; Fusanori Nishimura
Journal:  Clin Exp Dent Res       Date:  2016-11-24
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.